SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Avon Organics spurts on Mitsui & Company making strategic investment in it’s parent company

17 Jan 2013 Evaluate

Avon Organics is currently trading at Rs 28.40, up by 1.35 points or 4.99% from its previous closing of Rs 27.05 on the BSE.

The scrip opened at Rs 27.35 and has touched a high and low of Rs 28.90 and Rs 27.35 respectively. So far 64912 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 41.40 on 14-Mar-2012 and a 52 week low of Rs 17.30 on 31-Jul-2012.

Last one week high and low of the scrip stood at Rs 28.00 and Rs 26.50 respectively. The current market cap of the company is Rs 60.86 crore.

The promoters holding in the company stood at 63.60% while Institutions and Non-Institutions held 0.70% and 35.70% respectively. 

Japan based Mitsui & Company has made a strategic investment in Avon Organics’ parent company - Arch Pharmalabs (Arch) through a secondary market transaction, whereby the Japanese company has purchased 27.29% equity capital of Arch from private equity investors.

The transaction has been completed on January 16, 2013. Subsequent to which Mitsui & Company’s shareholding in Arch has increased from 4.67% to 31.96%.

Arch presently hold 63.60% equity capital of Avon Organics thereby making it a subsidiary company. However, there is no change envisaged/contemplated in the control and management of Arch Pharmalabs and/or at Avon Organics, pursuant to strategic investment by Mistui & Company in Arch. 

Kobo Biotech Share Price

2.58 -0.13 (-4.80%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×